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Abstract  
A few studies have revealed that the advanced glycation content of the vaginal wall in pelvic 
organ prolapse tissues is elevated. This elevation makes advanced glycation a significant 
association with the disease. Early detection of vaginal wall glycation could therefore be relevant 
in the prevention and management of pelvic organ prolapse. A vaginal wall biopsy to detect this 
would be ideal, but is invasive. Therefore the use of a more accessible organ to access, such as 
skin, would be beneficial. Our previous independent study suggests that conditions such as 
pregnancy, can induce a change in the vaginal tissues’ glycation content. The aim of this study 
was to assess whether the skin glycation undergoes similar changes as observed in vaginal tissue 
glycation in the same subjects in order to prove the hypothesis that skin advanced glycation 
content can predict vaginal tissue glycation. A rat model was used. The vaginal tissues from non-
pregnant and E15-E18 pregnant rats and skin tissues from the same rats were taken for the 
measurement of advanced glycation content. The glycation marker, pentosidine, was quantified 
by a high performance liquid chromatography. Our results demonstrated that glycation content in 
vaginal wall tissues from pregnant rats was lower than the tissues from non-pregnant ones, and a 
strong positive association between skin and vaginal wall pentosidine level was observed. We 
conclude that skin pentosidine is reflective of vaginal wall pentosidine. Skin glycation may 
therefore be a potential tool in the prediction and management of pelvic organ prolapse. 
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Introduction  
Pelvic organ prolapse is present in up to 50% of women presenting for routine gynaecological 
visits (1), with symptoms found in 8.4% of the general population (2). It is associated with 
multiple risk factors including age, multiple vaginal deliveries, chronically increased pelvic 
pressure, traumatic vaginal deliveries and obesity (3–5). Ageing is a focus of recent studies 
because pelvic organ prolapse occurs mostly in women above 40 years of age (6). Glycation-
associated ageing in particular is being investigated to obtain a better understanding of the cause 
and progression of pelvic organ prolapse (7–9). 
 
Glycation is a process in which proteins, fats and nucleic acids in body tissues get modified non-
enzymatically with reducing sugars, it typically occurs over months or years (10). It 
predominantly affects extracellular matrix (ECM) collagen and elastin because they have slow 
turnover rates within the ECM (11). Glycation results in stiffer, less digestible proteins and can 
permanently alter connective tissue properties (12). Advanced glycation is implicated in ageing 
and many diseases including gynaecological disorders such as pelvic organ prolapse and urinary 
incontinence (4, 5). Pelvic tissue glycation has been further studied since the observation of 
higher amounts of insoluble collagen or glycation products in prolapsed pelvic tissues by 
Jackson et al in 1996 (7).  
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Hypothesis/Theory 
There are currently no predictive tools for pelvic organ prolapse. The most common diagnostic 
techniques are based on physical pelvic examination (1,2,13,14). Due to the personal and private 
nature of pelvic problems and symptoms, diagnosis of pelvic organ prolapse often occurs when 
sufferers present with symptoms. As a result, more women have clinically evident prolapse than 
actually present with symptom to their health care provider (1). 
 
The consistent finding of higher vaginal wall glycation in women with pelvic organ prolapse in 
previous studies (7,8) suggests that the identification of vaginal wall glycation may be a useful 
tool for prediction, diagnosis and further management of pelvic organ prolapse. Vaginal tissue is 
poorly accessible and obtaining a vaginal biopsy is invasive and inconvenient for patients. The 
skin, on the contrary, is easily accessible and skin fluorescence can be measured non-invasively 
to reflect its advanced glycation levels (15). Since ageing is a generalized body process, it is 
expected that the various processes involved in ageing such as advanced glycation should occur 
at similar rates in different body tissues. We therefore hypothesize that skin glycation would 
reflect vaginal tissue glycation. 
 
Evaluation of Hypothesis 
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Ageing increases advanced glycation in the body continuously. Other conditions can regulate 
glycation content of body tissues. For example, advanced glycation is facilitated by oxidative 
stress (16). As a result, increased oxidative stress such as smoking and inflammation leads to a 
higher glycation content (17). On the contrary, elevation of the female hormone, estrogen causes 
the up-regulation of several antioxidants including a glycation reducing antioxidant, glyoxalase I 
(18). As a result, a lower glycation content has been observed in pregnant vaginal tissues in a rat 
model (19). Furthermore, it has been previously shown that skin glycation is lower during 
pregnancy (15). It is therefore reasonable to directly investigate skin glycation in relation to 
vaginal tissue glycation between pregnant and non-pregnant subjects by studying advanced 
glycation content of both tissues simultaneously from the same animals because the different 
hormone levels in pregnant and non-pregnant states should lead to different glycation levels. 
Proving this hypothesis implies that an assessment of skin glycation in women may be useful in 
the management of women with pelvic organ prolapse and a relevant predictive and preventive 
tool. 
 
Materials and Methods 
Tissue collections 
Full thickness skin and vaginal tissue from 6-8 month old pregnant (E15-E18) and 4 non-
pregnant female Sprague Dawley outbred rats were obtained following local ethical approval by 
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the Animal Welfare & Ethical Body Review and in accordance with the 2006 Animal Act. Skin 
segments from the left dorsal surface of the rats were used (20). 
 
Advanced glycation detection 
The advanced glycation marker, pentosidine, was chosen for detection due to its fluorescence 
property (9). Samples were lyophilised and hydrolysed in 6 M Hydrochloric acid at 110oC. High 
performance liquid chromatography (HPLC) separation and quantification was performed using 
a C-18 (250 mm (length) x 4.60 mm (width)) analytical column and ultraviolet (UV) detector. 
Standard pentosidine purchased from Caymann Chemical was used for the creation of a standard 
curve for quantification. Pentosidine was eluted at 9.6 minutes in a 30 minutes run using gradient 
ratios of 0.1% triflouroacetic acid and 80% acetonitrile. Detection of pentosidine occurred at 325 
nm wavelength.  
 
Statistics 
Means of the pregnant and non-pregnant groups were compared using an unpaired T test. 
Significance level was set at a p value of 0.05. Data are expressed as mean and standard error of 
mean. The Pearson correlation test was performed to study the relationship between vaginal and 
skin pentosidine. 
 
Results 
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The average skin pentosidine was obtained per gram dry tissue. Figure 1a shows that the average 
amounts of pentosidine were 0.007 mg/g and 0.014 mg/g in the pregnant and non-pregnant skin 
tissues respectively. There was minimal variability within groups and the difference was 
significant (p = 0.0002). Pentosidine in non-pregnant rat vaginal tissues was also significantly 
higher than in pregnant rat vaginal tissues (p = 0.042) as shown in Figure 1b. Although 
pentosidine levels in the skin were less than in the vaginal tissues, the pregnancy associated 
difference was more notable in the skin than in vaginal tissues. 
Pentosidine was higher in the vaginal tissue than in the skin of the same rats. Raised vaginal 
pentosidine was associated with raised skin pentosidine. A strong correlation (R2= 0.847) was 
present between the pentosidine content of vaginal and skin tissues of the same rats (Figure 2). 
 
Discussion/Consequences of Hypothesis 
Advanced glycation is a cause of ageing that has gained significant attention in recent times (8). 
Glycation considerably affects the skin. It results in increased skin stiffness, decreased elasticity 
and higher resistance to matrixmetalloproteinase enzyme degradation (21) which impedes 
connective tissue remodeling. Glycation induces inflammatory responses intracellularly and 
extracellularly (11). Advanced glycation end products can initiate DNA damage and stimulate 
cellular injury through their receptors, Receptor of Advanced Glycation End products, (RAGE) 
(11). 
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In our study, glycation was lower in the skin during pregnancy. This is congruent with a previous 
study noting reduced skin glycation-induced autoflourescence in pregnancy (15). Recently, 
vaginal tissue glycation was noted to be lower in pregnancy through influences on ER-α and 
glyoxalase I, an AGE lowering antioxidant (19). Another study has observed reduced glycation 
in vaginal tissues under oestrogen therapy (22). Oestrogen has also been found to influence 
blood vessel glycation. These, in conjunction with the present finding of reduced skin glycation 
in pregnancy suggest that pregnancy effects on glycation may be reflected in multiple body 
tissues and organs and the observation of known glycation-associated illnesses in one organ 
should warrant checks for others.  
 
A positive relationship between vaginal and skin tissue glycation content was also noted in this 
study and supports the hypothesis that skin glycation reflects vaginal tissue glycation level. 
Advanced glycation content has been studied in different tissues in the body because it is 
believed to be a global phenomenon occurring at reasonably similar rates in various sites of the 
body. Animal studies and human clinical trials have confirmed changes of advanced glycation 
content in a few other body tissues to be reflected in the skin (23–25). Mikulikova et al 
quantified pentosidine in tissues from rats with a high fructose intake and found that pentosidine 
accumulation increases in tendon, skin and aorta occurred at different rates, with pentosidine 
increasing more in the skin and aorta than in tendons accumulation when 10% fructose was 
given (24). Skin advanced glycation level has been used to predict advanced glycation level 
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associated diseases in other tissues for example, in the retina and cardiovascular system 
(23,25,26) but no previous study has correlated advanced glycation level between skin and 
vaginal tissues. We investigated collagen glycation levels of vaginal and skin tissues in 
pregnancy, a physiological process, and found correlation between the collagen altering 
glycation product, pentosidine in both tissues in the same rats, implying that collagen changes in 
connective tissues across the whole body may provide vital information for physiological and 
pathological processes. The correlation of glycation products in skin and other tissues, and the 
ease of access of the skin tissue for sampling or biopsy, lays a foundation for future studies on 
the predictive value of skin glycation in relation to vaginal tissue glycation, and thus its potential 
role in the investigation, prevention and management of glycation related gynaecological 
diseases. Our hypothesis is also supported by a recent study which revealed that ultra-structural 
collagen changes in the skin of women with pelvic organ prolapse (a pathological condition) 
correlated with changes in pelvic tissues of the same women (27). 
 
Further studies are required to determine whether the correlation of advanced glycation levels in 
skin and vaginal tissue holds in human subjects during physiological and pathological process. 
Furthermore, in pathological cases, it is important to note that changes in collagen metabolism 
may be the result or cause of a disease or physiological process. For example, in pelvic organ 
prolapse, the alteration of collagen metabolism in the vaginal wall may be a result of prior tissue 
weakening or stretching but not necessarily the cause of the prolapse (28). In such a condition, 
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collagen metabolism alterations or glycation levels may be more expressed in the vaginal wall 
than in skin tissues. 
 
Conclusion 
Our animal model study reveals that skin glycation correlates with vaginal wall glycation as both 
tissues respond similarly to a state of elevated oestrogen. This, in addition to previous literature 
demonstrating similar changes within the skin in response to changes in levels of the hormone, 
strongly suggests that skin glycation is reflective of vaginal tissue glycation, which is implicated 
in pelvic floor disorders. Skin glycation is a potentially useful marker in the prediction and 
diagnosis of glycation-associated pelvic floor diseases, with a view towards promoting 
preventive lifestyle. 
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Figure captions 
Figure 1: Measurement of AGE mark, pentosidine, by HPLC.  (a) Presented in skin tissues of 
pregnant and non-pregnant rats P=0.000; (b) presented in vaginal tissues from the same 
pregnant and non-pregnant rats. The data were re-presented from the publication (21) with 
the permission. 
Figure 2: Correlation of pentosidine expression between skin and vaginal tissues from the same 
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objects. R2=0.847. 
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